Significant response of a patient with mutant BRAFV600E Erdheim-Chester disease to Dabrafenib: A case report and literature review

Gil Verschelden
Belgian Society of Internal Medicine

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.